Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Panos Zanos(University of Cyprus), Todd D. Gould(University of Maryland, Baltimore)
Cited by 1,242
Related Papers
In Vivo Evidence in the Brain for Lithium Inhibition of Glycogen Synthase Kinase-3
|Neuropsychopharmacology|2003|216
β-Catenin Overexpression in the Mouse Brain Phenocopies Lithium-Sensitive Behaviors
|Neuropsychopharmacology|2007|137
Experimenters’ sex modulates mouse behaviors and neural responses to ketamine via corticotropin releasing factor
|Nature Neuroscience|2022|133
NMDA Receptor Activation-Dependent Antidepressant-Relevant Behavioral and Synaptic Actions of Ketamine
|Journal of Neuroscience|2023|104
Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis
|Molecular Psychiatry|2022|71